Aster Capital Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-352
Closed -$20.8K 1171
2025
Q4
$20.8K Buy
+352
New +$19.1K 0.01% 623
2025
Q2
Sell
-890
Closed -$42.4K 1395
2025
Q1
$42.4K Buy
890
+851
+2,182% +$37.7K 0.01% 855
2024
Q4
$1.59K Buy
+39
New +$1.62K ﹤0.01% 987

Other funds holding NGVT

Aster Capital Management's NGVT Position: Q1 2026 in Review

Aster Capital Management sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 352 shares — an estimated $20.8K sold.

Aster Capital Management first reported a position in NGVT in Q4 2024 and held it in 3 quarters. The position peaked at $42.4K in Q1 2025. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Aster Capital Management reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 352 Ingevity shares in Q1 2026, an estimated $20.8K.
  • Aster Capital Management first reported a position in Ingevity in Q4 2024 and held it in 3 quarters.
  • Aster Capital Management's Ingevity position peaked at $42.4K in Q1 2025.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.